top of page

First Alzheimer’s drug to slow disease progression gets full FDA approval

  • Writer: Care For A Cure
    Care For A Cure
  • Jul 9, 2023
  • 1 min read

The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.




Comments


Featured Posts
Recent Posts
Archive
Search By Tags
bottom of page